DXC Technology (DXC) Competitors

$8.90 -0.53 (-5.65%)

Closing price 03:59 PM Eastern

Extended Trading

$8.99 +0.09 (+1.03%)

As of 07:53 PM Eastern

DXC vs. QBTS, HQY, QMMM, FIGR, and AMTM

Should you be buying DXC Technology stock or one of its competitors? The main competitors of DXC Technology include D-Wave Quantum (QBTS), HealthEquity (HQY), QMMM (QMMM), Figure Technology Solutions (FIGR), and Amentum (AMTM). These companies are all part of the "business services" industry.

How does DXC Technology compare to D-Wave Quantum?

DXC Technology (NYSE:DXC) and D-Wave Quantum (NYSE:QBTS) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

96.2% of DXC Technology shares are held by institutional investors. Comparatively, 42.5% of D-Wave Quantum shares are held by institutional investors. 0.6% of DXC Technology shares are held by company insiders. Comparatively, 3.2% of D-Wave Quantum shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, DXC Technology had 1 more articles in the media than D-Wave Quantum. MarketBeat recorded 27 mentions for DXC Technology and 26 mentions for D-Wave Quantum. D-Wave Quantum's average media sentiment score of 0.58 beat DXC Technology's score of 0.33 indicating that D-Wave Quantum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DXC Technology	4 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
D-Wave Quantum	9 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

DXC Technology currently has a consensus price target of $13.50, suggesting a potential upside of 51.74%. D-Wave Quantum has a consensus price target of $35.53, suggesting a potential upside of 47.56%. Given DXC Technology's higher possible upside, equities research analysts plainly believe DXC Technology is more favorable than D-Wave Quantum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DXC Technology	3 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.73
D-Wave Quantum	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.76

DXC Technology has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, D-Wave Quantum has a beta of 1.95, suggesting that its stock price is 95% more volatile than the broader market.

DXC Technology has higher revenue and earnings than D-Wave Quantum. D-Wave Quantum is trading at a lower price-to-earnings ratio than DXC Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DXC Technology	$12.64B	0.12	$18M	$0.06	148.28
D-Wave Quantum	$24.59M	362.30	-$355.06M	-$1.10	N/A

DXC Technology has a net margin of 0.14% compared to D-Wave Quantum's net margin of -1,444.10%. DXC Technology's return on equity of 17.24% beat D-Wave Quantum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DXC Technology	0.14%	17.24%	4.35%
D-Wave Quantum	-1,444.10%	-58.58%	-48.13%

Summary

DXC Technology beats D-Wave Quantum on 10 of the 16 factors compared between the two stocks.

How does DXC Technology compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and DXC Technology (NYSE:DXC) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

HealthEquity has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market. Comparatively, DXC Technology has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market.

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 96.2% of DXC Technology shares are owned by institutional investors. 1.5% of HealthEquity shares are owned by insiders. Comparatively, 0.6% of DXC Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

HealthEquity has a net margin of 16.39% compared to DXC Technology's net margin of 0.14%. DXC Technology's return on equity of 17.24% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	16.39%	13.86%	8.67%
DXC Technology	0.14%	17.24%	4.35%

HealthEquity has higher earnings, but lower revenue than DXC Technology. HealthEquity is trading at a lower price-to-earnings ratio than DXC Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.25	$215.20M	$2.46	33.19
DXC Technology	$12.64B	0.12	$18M	$0.06	148.28

HealthEquity presently has a consensus price target of $111.79, suggesting a potential upside of 36.91%. DXC Technology has a consensus price target of $13.50, suggesting a potential upside of 51.74%. Given DXC Technology's higher probable upside, analysts plainly believe DXC Technology is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87
DXC Technology	3 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.73

In the previous week, DXC Technology had 17 more articles in the media than HealthEquity. MarketBeat recorded 27 mentions for DXC Technology and 10 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.33 beat DXC Technology's score of 0.33 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DXC Technology	4 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

HealthEquity beats DXC Technology on 11 of the 17 factors compared between the two stocks.

How does DXC Technology compare to QMMM?

DXC Technology (NYSE:DXC) and QMMM (NASDAQ:QMMM) are both business services companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

DXC Technology has a beta of 0.85, indicating that its share price is 15% less volatile than the broader market. Comparatively, QMMM has a beta of 16.15, indicating that its share price is 1,515% more volatile than the broader market.

DXC Technology has a net margin of 0.14% compared to QMMM's net margin of 0.00%. DXC Technology's return on equity of 17.24% beat QMMM's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DXC Technology	0.14%	17.24%	4.35%
QMMM	N/A	N/A	N/A

In the previous week, DXC Technology had 25 more articles in the media than QMMM. MarketBeat recorded 27 mentions for DXC Technology and 2 mentions for QMMM. DXC Technology's average media sentiment score of 0.33 beat QMMM's score of -0.54 indicating that DXC Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DXC Technology	4 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
QMMM	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

DXC Technology has higher revenue and earnings than QMMM.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DXC Technology	$12.64B	0.12	$18M	$0.06	148.28
QMMM	$2.70M	2,529.95	-$1.58M	N/A	N/A

96.2% of DXC Technology shares are held by institutional investors. 0.6% of DXC Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

DXC Technology presently has a consensus target price of $13.50, indicating a potential upside of 51.74%. Given DXC Technology's stronger consensus rating and higher probable upside, equities research analysts clearly believe DXC Technology is more favorable than QMMM.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DXC Technology	3 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.73
QMMM	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

DXC Technology beats QMMM on 11 of the 13 factors compared between the two stocks.

How does DXC Technology compare to Figure Technology Solutions?

Figure Technology Solutions (NASDAQ:FIGR) and DXC Technology (NYSE:DXC) are both business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

Figure Technology Solutions currently has a consensus target price of $53.75, indicating a potential upside of 37.93%. DXC Technology has a consensus target price of $13.50, indicating a potential upside of 51.74%. Given DXC Technology's higher probable upside, analysts plainly believe DXC Technology is more favorable than Figure Technology Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Figure Technology Solutions	2 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.64
DXC Technology	3 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.73

Figure Technology Solutions has higher earnings, but lower revenue than DXC Technology. Figure Technology Solutions is trading at a lower price-to-earnings ratio than DXC Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Figure Technology Solutions	$506.86M	13.97	$133.86M	$0.40	97.43
DXC Technology	$12.64B	0.12	$18M	$0.06	148.28

DXC Technology has a net margin of 0.14% compared to Figure Technology Solutions' net margin of 0.00%. DXC Technology's return on equity of 17.24% beat Figure Technology Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Figure Technology Solutions	N/A	N/A	N/A
DXC Technology	0.14%	17.24%	4.35%

96.2% of DXC Technology shares are owned by institutional investors. 26.6% of Figure Technology Solutions shares are owned by company insiders. Comparatively, 0.6% of DXC Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, DXC Technology had 20 more articles in the media than Figure Technology Solutions. MarketBeat recorded 27 mentions for DXC Technology and 7 mentions for Figure Technology Solutions. Figure Technology Solutions' average media sentiment score of 0.95 beat DXC Technology's score of 0.33 indicating that Figure Technology Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Figure Technology Solutions	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DXC Technology	4 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Figure Technology Solutions and DXC Technology tied by winning 8 of the 16 factors compared between the two stocks.

How does DXC Technology compare to Amentum?

DXC Technology (NYSE:DXC) and Amentum (NYSE:AMTM) are both business services companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

96.2% of DXC Technology shares are owned by institutional investors. Comparatively, 39.9% of Amentum shares are owned by institutional investors. 0.6% of DXC Technology shares are owned by insiders. Comparatively, 19.4% of Amentum shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

DXC Technology has a beta of 0.85, indicating that its stock price is 15% less volatile than the broader market. Comparatively, Amentum has a beta of 0.43, indicating that its stock price is 57% less volatile than the broader market.

DXC Technology currently has a consensus target price of $13.50, indicating a potential upside of 51.74%. Amentum has a consensus target price of $34.91, indicating a potential upside of 45.80%. Given DXC Technology's higher probable upside, research analysts clearly believe DXC Technology is more favorable than Amentum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DXC Technology	3 Sell rating(s)	8 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.73
Amentum	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

Amentum has a net margin of 0.69% compared to DXC Technology's net margin of 0.14%. DXC Technology's return on equity of 17.24% beat Amentum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DXC Technology	0.14%	17.24%	4.35%
Amentum	0.69%	11.56%	4.59%

In the previous week, DXC Technology had 22 more articles in the media than Amentum. MarketBeat recorded 27 mentions for DXC Technology and 5 mentions for Amentum. Amentum's average media sentiment score of 0.54 beat DXC Technology's score of 0.33 indicating that Amentum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DXC Technology	4 Very Positive mention(s)	7 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Amentum	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Amentum has higher revenue and earnings than DXC Technology. Amentum is trading at a lower price-to-earnings ratio than DXC Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DXC Technology	$12.64B	0.12	$18M	$0.06	148.28
Amentum	$14.39B	0.41	$66M	$0.40	59.86

Summary

Amentum beats DXC Technology on 10 of the 16 factors compared between the two stocks.

Get DXC Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DXC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DXC vs. The Competition

Export

Metric	DXC Technology	IT Services Industry	Computer Sector	NYSE Exchange
Market Cap	$1.60B	$12.95B	$39.00B	$22.90B
Dividend Yield	N/A	2.40%	3.16%	4.03%
P/E Ratio	148.28	49.20	164.93	28.90
Price / Sales	0.12	9.51	624.84	25.30
Price / Cash	0.90	25.48	46.29	19.21
Price / Book	0.47	3.59	9.54	4.65
Net Income	$18M	$544.53M	$1.03B	$1.07B
7 Day Performance	N/A	N/A	N/A	-1.20%
1 Month Performance	-21.99%	8.25%	16.83%	3.95%
1 Year Performance	-45.25%	-10.28%	173.99%	28.96%

DXC Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DXC DXC Technology	3.695 of 5 stars	$8.90 -5.7%	$13.50 +51.7%	-41.9%	$1.60B	$12.64B	148.28	120,000	News Coverage Earnings Report Analyst Forecast Gap Down High Trading Volume
QBTS D-Wave Quantum	3.2227 of 5 stars	$20.95 +2.3%	$35.53 +69.6%	+104.0%	$7.58B	$24.59M	N/A	3	Upcoming Earnings
HQY HealthEquity	4.3304 of 5 stars	$82.18 -0.3%	$111.79 +36.0%	-6.2%	$6.96B	$1.31B	33.41	2,814	Positive News Analyst Downgrade
QMMM QMMM	0.2457 of 5 stars	$119.40 +19.4%	N/A	+11,185.4%	$6.83B	$2.70M	N/A	N/A	High Trading Volume
FIGR Figure Technology Solutions	4.7681 of 5 stars	$36.04 -1.1%	$53.75 +49.1%	N/A	$6.62B	$506.86M	90.10	530

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:DXC) was last updated on 5/11/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DXC Technology (DXC) Competitors

DXC vs. QBTS, HQY, QMMM, FIGR, and AMTM

How does DXC Technology compare to D-Wave Quantum?

Summary

How does DXC Technology compare to HealthEquity?

Summary

How does DXC Technology compare to QMMM?

Summary

How does DXC Technology compare to Figure Technology Solutions?

Summary

How does DXC Technology compare to Amentum?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DXC vs. The Competition

DXC Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DXC Technology (DXC) Competitors

DXC vs. QBTS, HQY, QMMM, FIGR, and AMTM

How does DXC Technology compare to D-Wave Quantum?

Do institutionals and insiders have more ownership in DXC or QBTS?

Does the media prefer DXC or QBTS?

Do analysts recommend DXC or QBTS?

Which has more risk & volatility, DXC or QBTS?

Which has preferable valuation and earnings, DXC or QBTS?

Is DXC or QBTS more profitable?

Summary

How does DXC Technology compare to HealthEquity?

Which has more volatility and risk, HQY or DXC?

Do institutionals & insiders hold more shares of HQY or DXC?

Is HQY or DXC more profitable?

Which has stronger earnings and valuation, HQY or DXC?

Do analysts recommend HQY or DXC?

Does the media favor HQY or DXC?

Summary

How does DXC Technology compare to QMMM?

Which has more volatility & risk, DXC or QMMM?

Is DXC or QMMM more profitable?

Does the media prefer DXC or QMMM?

Which has stronger earnings & valuation, DXC or QMMM?

Do institutionals & insiders hold more shares of DXC or QMMM?

Do analysts rate DXC or QMMM?

Summary

How does DXC Technology compare to Figure Technology Solutions?

Do analysts recommend FIGR or DXC?

Which has preferable earnings & valuation, FIGR or DXC?

Is FIGR or DXC more profitable?

Do insiders and institutionals believe in FIGR or DXC?

Does the media prefer FIGR or DXC?

Summary

How does DXC Technology compare to Amentum?

Do insiders & institutionals believe in DXC or AMTM?

Which has more volatility and risk, DXC or AMTM?

Do analysts prefer DXC or AMTM?

Is DXC or AMTM more profitable?

Does the media refer more to DXC or AMTM?

Which has stronger valuation & earnings, DXC or AMTM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DXC vs. The Competition

DXC Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools